Skip to content
healthcare.dev

DOXORUBICIN HYDROCHLORIDE

NDC 49315-008, doxorubicin hydrochloride, injectable, liposomal, from Zydus Lifesciences Limited.

Product NDC
49315-008
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
INJECTABLE, LIPOSOMAL
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212299
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49315-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXORUBICIN HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
49315-008-03493150008031 VIAL, SINGLE-DOSE in 1 CARTON (49315-008-03) / 10 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bad467d4-7e27-4eda-b4d3-854460f0adab

Use it

Look up 49315-008 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49315-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49315-008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.